NDAINTRATHECALINJECTABLE
Approved
Feb 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
MPI INDIUM DTPA IN 111 (indium in-111 pentetate disodium) by GE HealthCare is radiopharmaceutical activity [moa]. Approved for radioactive diagnostic agent [epc]. First approved in 1982.
Drug data last refreshed 1h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MPI INDIUM DTPA IN 111 is a radioactive diagnostic agent containing indium-111 pentetate disodium, administered intrathecally to visualize cerebrospinal fluid dynamics and detect CNS abnormalities. It functions as a radiopharmaceutical that emits gamma radiation, enabling nuclear medicine imaging of the central nervous system. This legacy diagnostic imaging agent has been in clinical use since 1982 for cerebrospinal fluid flow studies and ventricular shunt patency assessment.
LOE Approaching
Product is in late-stage lifecycle with minimal growth opportunity; career focus should emphasize lifecycle management and transition planning rather than expansion.
Mechanism of Action
Radiopharmaceutical Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications (1)
Career Relevance
Careers on MPI INDIUM DTPA IN 111 emphasize specialized technical roles in nuclear medicine, radiochemistry, and manufacturing rather than commercial growth functions. Working on this product provides deep expertise in radiopharmaceutical science and established diagnostic protocols, ideal for professionals focused on technical mastery and operational stability.
Worked on MPI INDIUM DTPA IN 111 at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.